Document Detail


Comparison of urinary modified nucleosides and bases in rats with hepatomas and nephroblastomas.
MedLine Citation:
PMID:  6302750     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Hepatomas were induced in rats with aflatoxin B1, and nephroblastomas with dimethylnitrosamine. Microscopic examination of livers of aflatoxin-treated rats revealed multinodular hepatocyte hyperplasia at 8 months, and by 13 months all rats had hepatomas. Nephroblastomas were observed by 4 months and by 8 months all rats had developed them. The urinary excretion of several modified nucleosides and bases by normal rats is dependent on body weight and reflects, to a certain extent, their concentrations in tissue tRNA. Increased levels of several modified nucleosides and bases were found in all rats that had cancer. Rats with hepatomas excreted essentially the same modified nucleosides and bases as did those with nephroblastomas; the quantitative patterns of excretion were different, however, suggesting that the urinary modified nucleosides and bases may be used to differentiate between neoplasms. Although the increase in urinary modified nucleosides and bases by tumor-bearing animals results primarily from more rapid turnover of neoplastic tRNAs, the data indicate that increased turnover of mRNA and possibly rRNA may occur in neoplastic tissue. Preliminary data suggest that increases in urinary modified nucleosides and bases may occur during a precancerous stage. The urinary pattern of modified nucleosides and bases by rats with hepatomas is altered if another primary tumor is present. The results obtained from these studies support the use of modified nucleosides and bases in urine as biochemical markers of cancer.
Authors:
I Clark; J W MacKenzie; J R McCoy; W Lin
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer     Volume:  84     ISSN:  0080-0015     ISO Abbreviation:  Recent Results Cancer Res.     Publication Date:  1983  
Date Detail:
Created Date:  1983-06-10     Completed Date:  1983-06-10     Revised Date:  2008-02-13    
Medline Journal Info:
Nlm Unique ID:  0044671     Medline TA:  Recent Results Cancer Res     Country:  GERMANY, WEST    
Other Details:
Languages:  eng     Pagination:  388-400     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aflatoxin B1
Aflatoxins
Animals
Deoxyribonucleosides / urine
Dimethylnitrosamine
Kidney Neoplasms / urine*
Liver Neoplasms, Experimental / urine*
Male
Neoplasms, Experimental / urine
Nucleosides / urine*
Purines / urine*
Pyrimidines / urine*
Rats
Rats, Inbred Strains
Ribonucleosides / urine
Wilms Tumor / urine*
Chemical
Reg. No./Substance:
0/Aflatoxins; 0/Deoxyribonucleosides; 0/Nucleosides; 0/Purines; 0/Pyrimidines; 0/Ribonucleosides; 1162-65-8/Aflatoxin B1; 62-75-9/Dimethylnitrosamine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Alteration of enzymatic DNA methylation by chemical carcinogens.
Next Document:  Can DNA methylation regulate gene expression?